New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: In a push to upgrade primary education infrastructure, Chief Minister Mohan Charan Majhi on…
Bhubaneswar: Strengthening development in Kandhamal district, Odisha Chief Secretary Anu Garg reviewed key projects across…
Jagatsinghpur: Around 25 heritage enthusiasts from across Odisha participated in the 14th edition of the…
Bhubaneswar: Emphasising long-term development and citizen participation, Chief Minister Mohan Charan Majhi on Tuesday described…
Bhubaneswar: Odisha has emerged as a leading state in urban transformation, registering strong progress under…
Bhubaneswar: The seventh day of the ongoing Odia Pakhya was celebrated as “Shishu Katha Divas”…
